Home /Research /Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgery
SURGICAL

Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgery

Christopher M. Wright, Daniel Y. Lee, David Shimunov, Ruben Carmona, Andrew R. Barsky, Lova Sun, Roger B. Cohen, Joshua Bauml, Robert M. Brody, Devraj Basu, Christopher H. Rassekh, Ara A. Chalian, Jason G. Newman, Karthik Rajasekaran, Gregory S. Weinstein, John N. Lukens, Alexander Lin, Samuel Swisher‐McClure

Year
2021
Citations
16

Keywords

MedicineInternal medicineOncologyRadiation therapySystemic therapyCohortRetrospective cohort studyPrimary tumorCancerSurgery

Related papers

Browse all SURGICAL papers